Abstract

Psoriasis is an inflammatory skin disease with strong neutrophil (PMN) infiltration and high levels of the antimicrobial peptide, LL37. LL37 in complex with DNA and RNA is thought to initiate disease exacerbation via plasmacytoid dendritic cells. However, the source of nucleic acids supposed to start this initial inflammatory event remains unknown. We show here that primary murine and human PMNs mount a fulminant and self-propagating neutrophil extracellular trap (NET) and cytokine response, but independently of the canonical NET component, DNA. Unexpectedly, RNA, which is abundant in NETs and psoriatic but not healthy skin, in complex with LL37 triggered TLR8/TLR13-mediated cytokine and NET release by PMNs in vitro and in vivo. Transfer of NETs to naive human PMNs prompts additional NET release, promoting further inflammation. Our study thus uncovers a self-propagating vicious cycle contributing to chronic inflammation in psoriasis, and NET-associated RNA (naRNA) as a physiologically relevant NET component.

Antimicrobial peptide LL37 can bind nucleic acids and potentiate their sensing by endosomal TLRs. Here the authors show that LL37 binds to RNA from neutrophil extracellular traps (NETs), which amplifies inflammation and production of more LL37 and NETs via TLR8/13, suggesting that LL37 contribution to psoriasis may be fueled by NET-associated RNA.

Details

Title
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis
Author
Herster Franziska 1   VIAFID ORCID Logo  ; Bittner Zsofia 1 ; Archer, Nathan K 2 ; Dickhöfer Sabine 1 ; Eisel, David 3 ; Eigenbrod Tatjana 4 ; Knorpp, Thomas 5 ; Schneiderhan-Marra Nicole 5   VIAFID ORCID Logo  ; Löffler, Markus W 6   VIAFID ORCID Logo  ; Kalbacher Hubert 7   VIAFID ORCID Logo  ; Vierbuchen Tim 8   VIAFID ORCID Logo  ; Heine Holger 8   VIAFID ORCID Logo  ; Miller, Lloyd S 2 ; Hartl Dominik 9 ; Freund Lukas 10 ; Schäkel Knut 10   VIAFID ORCID Logo  ; Heister, Martin 11 ; Ghoreschi Kamran 12 ; Weber, Alexander N, R 1   VIAFID ORCID Logo 

 University of Tübingen, Department of Immunology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) 
 Johns Hopkins University School of Medicine, Department of Dermatology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 University of Tübingen, Department of Immunology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) ; David Eisel, BioNTech, Mainz, Germany (GRID:grid.434484.b) (ISNI:0000 0004 4692 2203) 
 University Hospital Heidelberg, Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
 NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany (GRID:grid.461765.7) (ISNI:0000 0000 9457 1306) 
 University of Tübingen, Department of Immunology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) ; University Hospital Tübingen, Department of General, Visceral and Transplant Surgery, Tübingen, Germany (GRID:grid.411544.1) (ISNI:0000 0001 0196 8249) ; University Hospital Tübingen, Department of Clinical Pharmacology, Tübingen, Germany (GRID:grid.411544.1) (ISNI:0000 0001 0196 8249) 
 Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) 
 Research Group Innate Immunity, Research Center Borstel, Leibniz Lung Center, Airway Research Center North (ARCN), Deutsches Zentrum für Lungenforschung (DZL), Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170) 
 University Children’s Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) ; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland (GRID:grid.419481.1) (ISNI:0000 0001 1515 9979) 
10  University Hospital Heidelberg, Department of Dermatology, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
11  University Hospital Tübingen, Department of Dermatology, Tübingen, Germany (GRID:grid.411544.1) (ISNI:0000 0001 0196 8249) 
12  University Hospital Tübingen, Department of Dermatology, Tübingen, Germany (GRID:grid.411544.1) (ISNI:0000 0001 0196 8249) ; Department of Dermatology, Charité – Universitätsmedizin Berlin, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2342961034
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.